// App-Quantinova.ai

FRI0040 (2018) : Development and validation of clinical predictors for inadequate response to treat-to-target methotrexate therapy in newly diagnosed ra patients

Researchers

Presenter

  • X.M. Teitsma

Principal Investigators

  • J.W. Jacobs

  • P.M. Welsing

  • P.H. de Jong

  • J.M. Hazes

  • A.E. Weel

  • A. Pethö-Schramm

  • M.E. Borm

  • J.M. van Laar

  • F.P. Lafeber

  • J.W. Bijlsma

Medical Centers

  • Reumatology & Clinical Immunology, UMC Utrecht, Utrecht

  • Rheumatology, Erasmus Medical Center, Rotterdam

  • Rheumatology, Maasstad hospital, Rotterdam, Netherlands

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Roche Nederland BV, Woerden, Netherlands

Locations

  • Netherlands

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • Tocilizumab

  • Etanercept

  • CHS-0214

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Roche Nederland BV

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved